MNPR financials
Monopar Therapeutics (MNPR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
MNPR income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | $0.00 | -$16.70M | -$13.72M | -1.85 |
| 2024 | $0.00 | $0.00 | -$16.16M | -$15.59M | -1.36 |
| 2023 | $0.00 | $0.00 | -$8.83M | -$8.40M | -0.58 |
| 2022 | $0.00 | $0.00 | -$10.54M | -$10.52M | -0.83 |
| 2021 | $0.00 | $0.00 | -$9.13M | -$9.10M | -0.73 |
| 2020 | $0.00 | $0.00 | -$6.51M | -$6.30M | -0.58 |